Anticoagulation Guidelines After Atrial Fibrillation Ablation

Introduction to Anticoagulation

The European Society of Cardiology recommends that patients with atrial fibrillation continue anticoagulation after ablation based on their CHA₂DS₂-VASc score, regardless of the success of the ablation procedure, to prevent ischemic stroke and thromboembolism 1, 2, 3
The American Heart Association and the European Heart Journal state that continuation of oral anticoagulation is recommended after AF ablation according to the patient's CHA₂DS₂-VASc score, and not the perceived success of the ablation procedure, to prevent ischemic stroke and thromboembolism 1, 2, 3

All patients must continue oral anticoagulation for at least 2 months after AF ablation, irrespective of rhythm outcome or CHA₂DS₂-VASc score, to reduce the risk of peri-procedural ischemic stroke and thromboembolism 1, 2, 3
The European Heart Journal recommends that males with CHA₂DS₂-VASc ≥2 or females with CHA₂DS₂-VASc ≥3 should continue anticoagulation indefinitely 4

The European Society of Cardiology guidelines state that anticoagulation decisions should be independent of rhythm outcome after ablation, and should be based on the patient's CHA₂DS₂-VASc score 1, 2, 3
The American College of Cardiology recommends that AF catheter ablation should not be performed with the sole intent of obviating the need for anticoagulation, as this is associated with increased stroke risk 6

The European Heart Journal recommends that direct oral anticoagulants (DOACs) are preferred over warfarin in most patients post-ablation, due to their lower bleeding risk 4
Options for DOACs include apixaban, rivaroxaban, edoxaban, or dabigatran, which have been shown to have lower rates of intracranial hemorrhage compared to warfarin 4